Common Sense Oncology: including everyone

Lancet Oncol. 2023 Oct;24(10):e402. doi: 10.1016/S1470-2045(23)00413-8.

Author

Nicolas André¹

Affiliation

¹ Service d'Hématologie et Oncologie Pédiatrique, Timone Hospital, AP-HM, Marseille, France; Reverse Molecular Pharmacology in Pediatric Oncology, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, CNRS, INSERM, Marseille, France; Metronomics Global Health Initiative, Marseille, France. Electronic address: nicolas.andre@ap-hm.fr.

PMID: 37797640
DOI: 10.1016/S1470-2045(23)00413-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Medical Oncology*